OpenVSafe by OpenVAERS
Search V-safe

ENN-13353-50292

3 vaccinations 4 coded responses 14 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
786 / TX
Registered
2021-12-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-25
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-15
    Dose 3 — Pfizer-BioNTech
  4. 2021-12-16
    Registered in v-safe
  5. 2021-12-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-12-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Diarrhea
    Adult check-in
  7. 2021-12-18
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2021-12-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-12-21
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Nasal congestion, Rhinorrhoea — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school
    Free text: Stuffy/runny nose, cough
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-22
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Nausea
    Adult check-in
  11. 2021-12-29
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2022-01-05
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  13. 2022-01-12
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-01-21
    Survey response — day 35, dose 3
    MedDRA: Cough, Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headache, cough
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-26
    Survey response — day 42, dose 3
    MedDRA: Migraine — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Migraines
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-03-16
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-06-17
    Survey response — 6 months, dose 3
    MedDRA: Delivery — Feeling: Good · Be unable to work or attend school
    Free text: Gave birth to baby
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-12-17
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-05-05Pfizer-BioNTech No
22021-05-25Pfizer-BioNTech No
32021-12-15Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-21

Systemic reaction (other): Stuffy/runny nose, cough

Release 11 — day 35, dose 3

2022-01-21

Symptoms: Headache, cough

Release 11 — day 42, dose 3

2022-01-26

Symptoms: Migraines

Release 12 — 6 months, dose 3

2022-06-17

Symptoms: Gave birth to baby

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDDelivery · · ✓
SDHeadache · · ✓
SDMigraine · · ✓
SROCough · · ✓
SRONasal congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release